| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |